封面
市場調查報告書
商品編碼
1298658

病毒載體製造市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Viral Vector Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

全球病毒載體製造市場規模在2022年達到9.61億美元。展望未來,IMARC Group預計,到2028年,市場價值將達到39.75億美元,在2023-2028年期間,成長率(CAGR)為24.9%。

病毒載體是分子生物學家用來將遺傳物質送入細胞的一種工具。它被用來替換有缺陷的基因以治愈遺傳性疾病,表達和呈現病原體抗原,通過模仿自然感染產生免疫反應。它被廣泛地應用於溶瘤療法,以瞄準和殺死腫瘤細胞。除此之外,由於它有助於治療不同的疾病,如心臟缺陷、代謝性疾病和神經退行性疾病,它在生命科學研究、基因治療和疫苗學方面有廣泛的應用。目前,由於基因突變和體內染色體受損的結合,遺傳性疾病的發病率不斷上升,病毒載體製造也隨之上升。

病毒載體製造的市場趨勢:

由於個人飲酒和久坐的生活方式的上升,癌症患者的增加代表了促進市場成長的關鍵因素之一。此外,全球範圍內對病毒載體進行的臨床研究數量也在增加。這一點,加上病毒載體在新型藥物遞送中的應用越來越多,正在對市場產生積極影響。除此之外,它們是病毒失能序列的有效載體,並被用來向人類造血幹細胞(HSCs)傳遞抑制艾滋病毒的轉基因。此外,一些國家的政府正在開展活動,以提高個人對病毒載體疫苗的認知。他們也在通過變革改善監管環境,如快速審批程序。此外,主要的市場參與者正在廣泛地投資於世界各地的生產活動的產能擴張。這些參與者還沉迷於合併和收購(M&A),這預計會增加他們的整體銷售和盈利能力。

目錄

第一章:前言

第二章:範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章:執行摘要

第四章:簡介

  • 概述
  • 主要行業趨勢

第五章:全球病毒載體製造市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按類型分類的市場

  • 腺病毒載體
    • 市場趨勢
    • 市場預測
  • 腺相關病毒載體
    • 市場趨勢
    • 市場預測
  • 慢病毒載體
    • 市場趨勢
    • 市場預測
  • 逆轉錄病毒載體
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章:按疾病分類的市場

  • 癌症
    • 市場趨勢
    • 市場預測
  • 遺傳性疾病
    • 市場趨勢
    • 市場預測
  • 傳染性疾病
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章:按應用分類的市場

  • 基因治療
    • 市場趨勢
    • 市場預測
  • 疫苗學
    • 市場趨勢
    • 市場預測

第九章:按終端用戶分類的市場

  • 製藥和生物製藥公司
    • 市場趨勢
    • 市場預測
  • 研究機構
    • 市場趨勢
    • 市場預測

第十章:按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章:SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章:價值鏈分析

第十三章:波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章:價格分析

第十五章:競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Cognate BioServices Inc. (Charles River Laboratories International Inc.)
    • F. Hoffmann-La Roche AG
    • FinVector Oy
    • FUJIFILM Holdings Corporation
    • Kaneka Eurogentec SA (Kaneka Corporation)
    • Lonza Group AG
    • Merck KGaA
    • Oxford Biomedica plc
    • REGENXBIO Inc.
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • uniQure NV
Product Code: SR112023A5016

The global viral vector manufacturing market size reached US$ 961 Million in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 3,975 Million by 2028, exhibiting a growth rate (CAGR) of 24.9% during 2023-2028.

A viral vector is a tool used by molecular biologists for delivering genetic materials into cells. It is used to replace defective genes for curing genetic disorders and express and present pathogenic antigens for generating an immune response by mimicking a natural infection. It is widely employed in oncolytic therapies to target and kill tumor cells. Besides this, as it assists in treating different diseases, such as heart defects, metabolic diseases, and neurodegenerative disorders, it finds extensive applications in life science research, gene therapy and vaccinology. At present, there is a rise in viral vector manufacturing on account of the rising prevalence of genetic disorders due to a combination of gene mutations and damaged chromosomes in the body.

Viral Vector Manufacturing Market Trends:

The increasing cancer patients due to the rising alcohol consumption and sedentary lifestyles of individuals represents one of the key factors contributing to the growth of the market. In addition, there is a rise in the number of clinical studies undertaken on viral vectors across the globe. This, along with the growing utilization of viral vectors in novel drug delivery, is positively influencing the market. Besides this, they are efficient carriers of virus-disabling sequences and are used to deliver HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs). Additionally, governments of several countries are launching campaigns to generate awareness about viral vector vaccines among individuals. They are also improving the regulatory environment via changes, such as fast-track approval processes. Furthermore, key market players are extensively investing in capacity expansion for manufacturing activities around the world. These players are also indulging in mergers and acquisitions (M&A), which is projected to increase their overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global viral vector manufacturing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease, application and end user.

Breakup by Type:

Adenoviral Vectors

Adeno-associated Viral Vectors

Lentiviral Vectors

Retroviral Vectors

Others

Breakup by Disease:

Cancer

Genetic Disorders

Infectious Diseases

Others

Breakup by Application:

Gene Therapy

Vaccinology

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.

Key Questions Answered in This Report

1. What was the size of the global viral vector manufacturing market in 2022?

2. What is the expected growth rate of the global viral vector manufacturing market during 2023-2028?

3. What has been the impact of COVID-19 on the global viral vector manufacturing market?

4. What are the key factors driving the global viral vector manufacturing market?

5. What is the breakup of the global viral vector manufacturing market based on the type?

6. What is the breakup of the global viral vector manufacturing market based on the disease?

7. What is the breakup of the global viral vector manufacturing market based on the application?

8. What are the key regions in the global viral vector manufacturing market?

9. Who are the key players/companies in the global viral vector manufacturing market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Viral Vector Manufacturing Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Type

  • 6.1  Adenoviral Vectors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Adeno-associated Viral Vectors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Lentiviral Vectors
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Retroviral Vectors
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7   Market Breakup by Disease

  • 7.1  Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Genetic Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Infectious Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Application

  • 8.1  Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Vaccinology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Pharmaceutical and Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Cognate BioServices Inc. (Charles River Laboratories International Inc.)
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  F. Hoffmann-La Roche AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3  FinVector Oy
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  FUJIFILM Holdings Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Kaneka Eurogentec S.A. (Kaneka Corporation)
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6  Lonza Group AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Oxford Biomedica plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  REGENXBIO Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12  uniQure N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials

List of Figures

  • Figure 1: Global: Viral Vector Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Viral Vector Manufacturing Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Viral Vector Manufacturing Market: Breakup by Disease (in %), 2022
  • Figure 6: Global: Viral Vector Manufacturing Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Viral Vector Manufacturing Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Viral Vector Manufacturing Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Viral Vector Manufacturing (Retroviral Vectors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Viral Vector Manufacturing (Retroviral Vectors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Viral Vector Manufacturing (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Viral Vector Manufacturing (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Viral Vector Manufacturing (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Viral Vector Manufacturing (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Viral Vector Manufacturing (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Viral Vector Manufacturing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Viral Vector Manufacturing (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Viral Vector Manufacturing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Viral Vector Manufacturing (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Viral Vector Manufacturing (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Viral Vector Manufacturing (Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Viral Vector Manufacturing (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Viral Vector Manufacturing (Vaccinology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Viral Vector Manufacturing (Vaccinology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Viral Vector Manufacturing (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Viral Vector Manufacturing (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Viral Vector Manufacturing Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Viral Vector Manufacturing Industry: SWOT Analysis
  • Figure 85: Global: Viral Vector Manufacturing Industry: Value Chain Analysis
  • Figure 86: Global: Viral Vector Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viral Vector Manufacturing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Viral Vector Manufacturing Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Viral Vector Manufacturing Market Forecast: Breakup by Disease (in Million US$), 2023-2028
  • Table 4: Global: Viral Vector Manufacturing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Viral Vector Manufacturing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Viral Vector Manufacturing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Viral Vector Manufacturing Market: Competitive Structure
  • Table 8: Global: Viral Vector Manufacturing Market: Key Players